
The Role of Tear Film Biomarkers in Diagnosing and Managing DED
Damon Dierker, OD, FAAO, Director of Clinical Strategy & Optometric Services at Eye Surgeons of Indiana, hosted Jerry Robben, OD, chief optometrist and director of clinical research at Bowden Eye and Associates in Jacksonville, Florida, and adjunct clinical assistant professor at the Arizona College of Optometry, for a Dry Eye Fireside Chat on tear film biomarkers. More than a decade ago, Dr. Robben’s first matrix metalloproteinase 9 (MMP-9) test contradicted his slit lamp exam. Today, his team runs osmolarity and MMP-9 on every suspected dry eye patient before the doctor walks in. Osmolarity anchors the diagnosis and the follow-up, and MMP-9 exposes inflammation that a quiet-looking eye can hide. Dry Eye Fireside Chat is independently editorial content supported by advertising from Bausch + Lomb. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, and materials available herein are for general information purposes only.